Management of Invasive Fungal Infection: Clinical Strategies in Critical Care from a Multidisciplinary Consensus

Area of Science:

• Infectious Diseases
• Clinical Pharmacology
• Critical Care Medicine

Background:

• Invasive fungal infections (IFIs) present a significant and increasing challenge in hospital settings.
• Critically ill and immunocompromised patients are particularly vulnerable to severe outcomes from IFIs.
• Expert consensus is needed to address the rising incidence and complexity of IFIs in critical care.

Purpose of the Study:

• To consolidate clinical strategies for the timely diagnosis and management of invasive fungal infections.
• To provide guidance on personalized pharmacologic interventions and antifungal stewardship.
• To optimize patient outcomes in critical care settings through integrated management approaches.

Main Methods:

• A multidisciplinary consensus involving fifteen clinical experts from Northern Italy.
• Review of current challenges and best practices in diagnosing and treating IFIs.
• Evaluation of diagnostic tools, biomarkers, and therapeutic drug monitoring.

Main Results:

• Azole antifungals are recommended as first-line treatment options.
• Isavuconazole is highlighted as a preferred agent due to its pharmacokinetic profile, renal safety, and lack of QT prolongation.
• Emphasis on integrating early recognition, rapid diagnostics, and individualized therapy.

Conclusions:

• Integrated strategies combining early recognition, rapid diagnostics, and individualized pharmacology are crucial for improving outcomes.
• Antifungal stewardship is essential for responsible and effective management of IFIs.
• This consensus provides a framework for optimizing the care of patients with invasive fungal infections in critical settings.